Abbott Laboratories Stock Deutsche Boerse AG
Stocks
ABL0
CA0028221046
Medical Equipment, Supplies & Distribution
|
Delayed
Deutsche Boerse AG
10:50:13 07/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 10.70 EUR | -1.83% |
|
-1.83% | -20.15% |
| 04:14pm | Barclays Initiates Coverage on Abbott Laboratories With Overweight Rating, $120 Price Target | MT |
| 10-05 | Abbott Laboratories Receives FDA Approval for New CardioMEMS HF System capabilities | CI |
| Market Cap | 170B 151B 141B 128B 242B 16,374B 243B 1,695B 659B 8,353B 638B 624B 26,853B | P/E 2026 * |
28.7x | P/E 2027 * | 22.3x |
|---|---|---|---|---|---|
| Enterprise Value | 194B 172B 161B 146B 276B 18,681B 278B 1,934B 752B 9,530B 727B 712B 30,637B | EV / Sales 2026 * |
3.86x | EV / Sales 2027 * | 3.5x |
| Free-Float |
86.16% | Yield 2026 * |
2.62% | Yield 2027 * | 2.79% |
| Markets | Quality | ||
|---|---|---|---|
Deutsche Boerse AG
| ABL0 | Delayed | |
Toronto S.E.
| ABT | Delayed |
Last Transcript: Abbott Laboratories
| 1 day | -1.83% | ||
| 1 week | -1.83% | ||
| Current month | -1.83% | ||
| 1 month | -9.32% | ||
| 3 months | +3.88% | ||
| 6 months | -5.31% | ||
| Current year | -20.15% |
| 1 week | 10.6 |  | 10.9 |
| 1 month | 10.6 | | 11.8 |
| Current year | 9.2 | | 14.8 |
| 1 year | 9.2 | | 14.8 |
| 3 years | 9.2 | | 16 |
| 5 years | 9.2 | | 16 |
| 10 years | 9.2 | | 16 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 31/03/2020 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 01/09/2023 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 09/12/2011 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 09/12/2011 |
Daniel Starks
BRD | Director/Board Member | 71 | 16/02/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.83% | -1.83% | - | - | 170B | |
| +0.20% | -2.76% | -26.60% | +1.32% | 170B | |
| +0.24% | 0.00% | -11.52% | +14.41% | 111B | |
| +0.89% | -0.20% | -24.05% | +4.65% | 107B | |
| -0.68% | +0.21% | -47.21% | -10.66% | 75.95B | |
| +0.78% | +2.85% | +3.63% | +72.08% | 60.37B | |
| -0.65% | +6.59% | +11.44% | +66.40% | 53.53B | |
| -0.26% | -0.92% | -6.09% | -31.29% | 49.11B | |
| -0.87% | -3.38% | -17.90% | +15.57% | 40.6B | |
| +1.67% | -3.75% | +25.66% | +0.20% | 31.47B | |
| Average | +0.09% | +0.25% | -10.29% | +14.74% | 77.67B | |
| Weighted average by Cap. | -0.05% | -0.04% | -16.22% | +12.19% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 50.2B 44.56B 41.7B 37.8B 71.39B 4,839B 71.9B 501B 195B 2,469B 188B 184B 7,936B | 54.53B 48.4B 45.3B 41.06B 77.54B 5,256B 78.1B 544B 212B 2,681B 205B 200B 8,620B |
| Net income | 6.21B 5.51B 5.16B 4.68B 8.83B 599B 8.9B 61.98B 24.11B 305B 23.32B 22.82B 982B | 7.89B 7.01B 6.56B 5.94B 11.22B 761B 11.31B 78.76B 30.63B 388B 29.63B 28.99B 1,248B |
| Net Debt | 23.94B 21.25B 19.89B 18.03B 34.04B 2,308B 34.29B 239B 92.9B 1,177B 89.86B 87.93B 3,785B | 20.96B 18.6B 17.41B 15.78B 29.8B 2,020B 30.02B 209B 81.33B 1,031B 78.66B 76.98B 3,313B |
| Date | Price | Change |
|---|---|---|
| 07/10/26 | €10.70 | -1.83% |
| 06/10/26 | €10.90 | +2.83% |
| 05/10/26 | €10.60 | -0.93% |
| 02/10/26 | €10.70 | 0.00% |
| 01/10/26 | €10.70 | -1.83% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABT Stock
- ABL0 Stock
Select your edition
All financial news and data tailored to specific country editions
